We also performed methylome profiling of glioma tissues (GBM WHO IV), and the primary GBM cells derived from the tissues were characterized for the mutational status of IDH1/IDH2, p53, and methylation of MGMT (Table 1) as described in Materials and Methods. The gene discussed is IDH2; the disease is central nervous system cancer.